A Preview Of Intellia Therapeutics's Earnings
Portfolio Pulse from Benzinga Insights
Intellia Therapeutics (NASDAQ:NTLA) is scheduled to release its quarterly earnings report on February 22, 2024, with an expected EPS of $-1.45. Historical data shows mixed reactions to past earnings, with the last quarter beating estimates but resulting in a 3.33% share price drop. Over the last year, NTLA shares have declined by 32.31%, indicating a bearish sentiment among long-term shareholders.
February 21, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Intellia Therapeutics is expected to report an EPS of $-1.45 for the upcoming earnings, with historical performance showing mixed reactions to past earnings reports. Shares have declined by 32.31% over the last year, indicating bearish sentiment.
The expected EPS and historical performance suggest a cautious outlook for NTLA's short-term stock price movement. The significant decline in share price over the past year reflects a bearish sentiment, but the actual earnings result and future guidance will be key drivers for any immediate price changes.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100